newsfilter
← Latest News
Business Wire·

CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

CareDx Exclusive Provider of dd-cfDNA Testing Services for Use in Miromatrix Clinical Trials Companies at Forefront of Alternative Organ Supply Research to Address Organ Shortage CareDx, Inc. (NASDAQ:CDNA) and